Zobrazeno 1 - 10
of 42
pro vyhledávání: '"V Altomonte"'
Publikováno v:
Bone Marrow Transplantation. 24:517-520
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse mortality. The improved management of acute GVHD has not translated into lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b819969ec5c746a3eeb5ab5afe628b4e
https://doi.org/10.1038/sj.bmt.1701936
https://doi.org/10.1038/sj.bmt.1701936
Autor:
Georgia B. Vogelsang, Shoshan Nevo, V Altomonte, Hayden G. Braine, Valerie Swan, Kirk J. Wojno, Alice K. Fuller, Stephen J. Noga, Cheryl Enger
Publikováno v:
Transplantation. 67:681-689
Background. Hemorrhagic complications are frequently implicated clinically for the high morbidity and mortality of acute graft versus host disease (GVHD), however, only few reports characterize the incidence and timing of bleeding in relation to GVHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd3490259889328508907cff193cf606
https://doi.org/10.1097/00007890-199903150-00007
https://doi.org/10.1097/00007890-199903150-00007
Autor:
Evan R. Farmer, J. Grant, C.S. Freemer, V Altomonte, Thomas Horn, Deborah Marcellus, Georgia B. Vogelsang
Publikováno v:
Blood. 93:66-70
Chronic graft-versus-host disease (GVHD) is the most common late complication of allogeneic bone marrow transplantation (BMT). The sclerodermatous form of the disease is often refractory to standard treatment modalities. Based on reports of response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6aa5f9e19bb60d9d0b5fa7f727cf0ac
https://doi.org/10.1182/blood.v93.1.66.401k10_66_70
https://doi.org/10.1182/blood.v93.1.66.401k10_66_70
Autor:
George W. Santos, V Altomonte, Allan D. Hess, Evan R. Farmer, Georgia B. Vogelsang, Richard J. Jones, Andrew M. Yeager
Publikováno v:
Blood. 79:3031-3035
Cutaneous graft-versus-host disease (GVHD) has been reported after administration of cyclosporine (CSP) after autologous bone marrow transplantation (ABMT) with unpurged marrow in patients with lymphoma. To determine whether GVHD can be induced after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f4eb6963ee710070468494b225ed3f3
https://doi.org/10.1182/blood.v79.11.3031.bloodjournal79113031
https://doi.org/10.1182/blood.v79.11.3031.bloodjournal79113031
Autor:
J M Davis, E Bright, V Altomonte, G Vogelsang, Allan D. Hess, S Bond, J L Passos-Coehlo, J Fetting, K V Ohly, T Horn, M J Kennedy, Deborah K. Armstrong, J Thomassen, K McIntyre, Nancy E. Davidson, E. van der Wall, Stephen J. Noga, S M Lee, B Clarke
Publikováno v:
British Journal of Cancer, 83(11), 1405. Nature
British Journal of Cancer
British Journal of Cancer
The purpose of the present study was to investigate the impact of the use of peripheral blood progenitor cells (PBPCs) on the induction of autologous graft-versus-host disease (GVHD) in patients with advanced breast cancer. 14 women with stage IIIB a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae42521503715a926c5b60616176bd1
https://dspace.library.uu.nl/handle/1874/21606
https://dspace.library.uu.nl/handle/1874/21606
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial
Autor:
Thomas Horn, S Piantadosi, V Altomonte, Deborah Marcellus, Georgia B. Vogelsang, Ross A. Abrams, A. D. Hess, Richard J. Jones, R. Bitton, Carole B. Miller
Publikováno v:
Bone marrow transplantation. 24(6)
From March 1994 to November 1994, 16 patients with high risk hematological malignancies were entered in a phase I clinical trial, designed to confirm the toxicity of cyclosporine and gamma interferon given to induce autologous graft-versus-host disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a8b4b276059cb2c7b920509212a955
https://pubmed.ncbi.nlm.nih.gov/10490729
https://pubmed.ncbi.nlm.nih.gov/10490729
Autor:
S, Nevo, C, Enger, V, Swan, K J, Wojno, A K, Fuller, V, Altomonte, H G, Braine, S J, Noga, G B, Vogelsang
Publikováno v:
Transplantation. 67(5)
Hemorrhagic complications are frequently implicated clinically for the high morbidity and mortality of acute graft versus host disease (GVHD), however, only few reports characterize the incidence and timing of bleeding in relation to GVHD, and essent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34b85cccd26fc73bbe521fb024ccec54
https://pubmed.ncbi.nlm.nih.gov/10096522
https://pubmed.ncbi.nlm.nih.gov/10096522
Autor:
V Altomonte, Susan K. Wright, Georgia B. Vogelsang, R L Humphrey, Hayden G. Braine, Ephraim J. Fuchs, A. Seber, K G Schepers, S. J. Noga, Richard J. Jones
Publikováno v:
Bone marrow transplantation. 22(3)
Two patients with multiple myeloma in relapse after allogeneic BMT received donor lymphocyte infusions (DLI) but later required chemotherapy for treatment of myeloma-related complications. In both patients, recovery from chemotherapy-induced aplasia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a06d15bf687543a7872bcd2a1036bed
https://pubmed.ncbi.nlm.nih.gov/9720749
https://pubmed.ncbi.nlm.nih.gov/9720749
Publikováno v:
Journal of the American Academy of Dermatology. 34(3)
Background: Allogeneic graft-versus-host disease is associated with decreased rates of tumor relapse. The addition of interferon gamma to cyclosporine, given to induce graft-versus-host disease after autologous bone marrow transplantation, increases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a84baae898123ed532fe7c8dda4bedc
https://pubmed.ncbi.nlm.nih.gov/8609251
https://pubmed.ncbi.nlm.nih.gov/8609251
Autor:
M J Kennedy, Nancy E. Davidson, Georgia B. Vogelsang, Evan R. Farmer, V Altomonte, A M Huelskamp, Allan D. Hess, Richard J. Jones
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 12(2)
PURPOSE We investigated if interferon gamma (IFN-gamma) could augment cyclosporine (CSA)-induced graft-versus-host disease (GVHD) following autologous bone marrow transplant in women with metastatic breast cancer and defined the toxicities of this th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57431d870e8570e3f980e2ba172c1b3
https://pubmed.ncbi.nlm.nih.gov/8113831
https://pubmed.ncbi.nlm.nih.gov/8113831